MedPath

Zithranol

Approved
Approval ID

253fdee7-5060-4b49-ad26-257eb54cccfa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 17, 2014

Manufacturers
FDA

Elorac Inc.

DUNS: 832590009

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Anthralin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42783-111
Product Classification
G
Generic Name
Anthralin
Product Specifications
Route of AdministrationTOPICAL
Effective DateOctober 17, 2014
FDA Product Classification

INGREDIENTS (8)

GLYCERETH-2 COCOATEInactive
Code: JWM00VS7HC
Classification: IACT
AnthralinActive
Quantity: 1 g in 100 g
Code: U8CJK0JH5M
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
GLYCERYL LAURATEInactive
Code: Y98611C087
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
GLYCERYL MYRISTATEInactive
Code: 6992Y81827
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zithranol - FDA Drug Approval Details